CIK: 0001609251
申告総資産額
$2.6億
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Bioverativ INC | 株式-その他 | 12.95% | — | -5.05% | |
| 2 | ENTA | Enanta Pharmaceuticals INC | 株式-その他 | 12.07% | -1.25% | +0.59% | |
| 3 | GILD | Gilead Sciences INC | 株式-ヘルスケア | 11.44% | — | -0.85% | |
| 4 | UTHR | United Therapeutics CORP | 株式-ヘルスケア | 10.75% | +3.84% | +16.30% | |
| 5 | ✓ | Sucampo Pharmaceuticals INC | 株式-その他 | 8.99% | — | +0.59% | |
| 6 | OFIX | Orthofix Medical Inc. | 株式-その他 | 8.24% | — | -16.29% | |
| 7 | RTIXEUR | Rti Surgical Hds INC | 株式-その他 | 7.93% | — | +0.59% | |
| 8 | MRK | Merck & Co. INC. | 株式-ヘルスケア | 7.44% | — | -0.62% | |
| 9 | ✓ | Halyard Health Incorporated | 株式-その他 | 6.81% | — | -2.33% | |
| 10 | IVCUSD | Invacare CORP | 株式-その他 | 4.49% | — | -2.57% | |
| 11 | ✓ | Unilife CORP New | 株式-その他 | 4.03% | — | — | |
| 12 | CNMD | Conmed CORP | 株式-その他 | 3.50% | — | -36.43% | |
| 13 | ✓ | Aviragen Therapeutics INC | 株式-その他 | 0.58% | — | — | |
| 14 | ✓ | Digirad CORP | 株式-その他 | 0.41% | — | — | |
| 15 | ✓ | Juniper Pharmaceuticals Incorporated | 株式-その他 | 0.37% | — | — |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | RTIXEUR | Rti Surgical Hds INC | +2.2% | +0.59% | 増加 |
| 2 | ENTA | Enanta Pharmaceuticals INC | +1.2% | +0.59% | 増加 |
| 3 | UTHR | United Therapeutics CORP | +0.5% | +16.30% | 増加 |
| 4 | IVCUSD | Invacare CORP | +0.1% | -2.57% | 減少 |
| 5 | ✓ | Juniper Pharmaceuticals Incorporated | — | — | 変化なし |
| 6 | ✓ | Aviragen Therapeutics INC | 0% | — | 変化なし |
| 7 | ✓ | Bioverativ INC | -0.2% | -5.05% | 減少 |
| 8 | ✓ | Digirad CORP | -0.2% | — | 変化なし |
| 9 | GILD | Gilead Sciences INC | -0.3% | -0.85% | 減少 |
| 10 | OFIX | Orthofix Medical Inc. | -0.3% | -16.29% | 減少 |
| 11 | ✓ | Halyard Health Incorporated | -0.4% | -2.33% | 減少 |
| 12 | MRK | Merck & Co. INC. | -0.4% | -0.62% | 減少 |
| 13 | ✓ | Sucampo Pharmaceuticals INC | -1% | +0.59% | 増加 |
| 14 | CNMD | Conmed CORP | -1.6% | -36.43% | 減少 |
| 15 | ✓ | Unilife CORP New | — | NEW | 新規購入 |
| 16 | AMGN | Amgen INC | — | EXIT | 全売却 |